GB1526331A — Phthalanes
Assigned to H Lundbeck AS · Expires 1978-09-27 · 48y expired
What this patent protects
1526331 Phthalanes KEFALAS AS 6 Jan 1977 [14 Jan 1976] 01486/76 Heading C2C Novel compounds of Formula I wherein R<SP>1</SP> and R<SP>2</SP> are each halogen, CF 3 , CN, or C 2-5 alkanoyl and acid addition salts thereof are prepared by standard methods. I…
USPTO Abstract
1526331 Phthalanes KEFALAS AS 6 Jan 1977 [14 Jan 1976] 01486/76 Heading C2C Novel compounds of Formula I wherein R<SP>1</SP> and R<SP>2</SP> are each halogen, CF 3 , CN, or C 2-5 alkanoyl and acid addition salts thereof are prepared by standard methods. Intermediates and starting materials are also isolated. Pharmaceutical compositions in conventional forms and having antidepressant activity comprise an above novel compound and a carrier or diluent.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.